Joan Bolt‐de Vries

2.0k citations

34 papers · 1.4k indexed · h-index 20

Cancer Research top 5%
Oncology top 5%
Molecular Biology
Pulmonary and Respiratory Medicine top 5%
Genetics top 10%

Co-authors: John A. Foekens Maxime P. Look John W.M. Martens Anieta M. Sieuwerts Marion E. Meijer‐van Gelder Jaco Kraan Bianca Mostert Stefan Sleijfer
Topics: Hormonal and reproductive studies (15 papers)Prostate Cancer Treatment and Research (10 papers)Cancer Cells and Metastasis (9 papers)
Cited by: Cancer Research Oncology Endocrinology, Diabetes and Metabolism
Journals: Journal of Clinical Oncology JNCI Journal of the National Cancer Institute Cancer Research
Partner nations: Netherlands Germany Spain

In The Last Decade

Joan Bolt‐de Vries

34 papers receiving 1.3k citations

Peers

Countries citing papers authored by Joan Bolt‐de Vries

Since Specialization

Citations

This map shows the geographic impact of Joan Bolt‐de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Bolt‐de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Bolt‐de Vries more than expected).

Fields of papers citing papers by Joan Bolt‐de Vries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Bolt‐de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Bolt‐de Vries. The network helps show where Joan Bolt‐de Vries may publish in the future.

Co-authorship network of co-authors of Joan Bolt‐de Vries

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Bolt‐de Vries. A scholar is included among the top collaborators of Joan Bolt‐de Vries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Bolt‐de Vries. Joan Bolt‐de Vries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients 2015 ·Molecular Oncology ·Bianca Mostert,Anieta M. Sieuwerts,Joan Bolt‐de Vries,Jaco Kraan,Zarina S. Lalmahomed,Anne van Galen,Petra van der Spoel,Vanja de Weerd,Raquel Ramírez‐Moreno,Marcel Smid,Cornelis Verhoef,Jan N.M. IJzermans,Jan W. Gratama,Stefan Sleijfer,John A. Foekens,John W.M. Martens	39
2	Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients 2014 ·Annals of Oncology ·Bianca Mostert,Anieta M. Sieuwerts,Jaco Kraan,Joan Bolt‐de Vries,Petra van der Spoel,Anne van Galen,Dieter Peeters,Luc Dirix,Caroline Seynaeve,Agnes Jager,Felix E. de Jongh,Paul Hamberg,Jacqueline M. Stouthard,Diederik F.S. Kehrer,Maxime P. Look,Marcel Smid,J.W. Gratama,John A. Foekens,John W.M. Martens,Stefan Sleijfer	45
3	Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice 2014 ·Breast Cancer Research and Treatment ·Muhammad Riaz,Buddy Setyono-Han,Mieke Timmermans,Anita M.A.C. Trapman,Joan Bolt‐de Vries,Antoinette Hollestelle,Roel C. Janssens,Maxime P. Look,Mieke Schutte,John A. Foekens,John W.M. Martens	6
4	KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue 2012 ·International Journal of Cancer ·Bianca Mostert,Yuqiu Jiang,Anieta M. Sieuwerts,Haiying Wang,Joan Bolt‐de Vries,Katharina Biermann,Jaco Kraan,Zarina S. Lalmahomed,Anne van Galen,Vanja de Weerd,Petra van der Spoel,Raquel Ramírez‐Moreno,Cornelis Verhoef,Jan N.M. IJzermans,Yixin Wang,Jan‐Willem Gratama,John A. Foekens,Stefan Sleijfer,John W.M. Martens	110
5	CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes 2011 ·Cancer Letters ·Bianca Mostert,Jaco Kraan,Anieta M. Sieuwerts,Petra van der Spoel,Joan Bolt‐de Vries,Wendy J. C. Prager‐van der Smissen,Marcel Smid,A. Mieke Timmermans,John W.M. Martens,Jan W. Gratama,John A. Foekens,Stefan Sleijfer	41
6	Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR 2008 ·Breast Cancer Research and Treatment ·Anieta M. Sieuwerts,Jaco Kraan,Joan Bolt‐de Vries,Petra van der Spoel,Bianca Mostert,John W.M. Martens,Jan‐Willem Gratama,Stefan Sleijfer,John A. Foekens	145
7	DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients 2007 ·Breast Cancer Research and Treatment ·Inko Nimmrich,Anieta M. Sieuwerts,Marion E. Meijer‐van Gelder,(unknown),Joan Bolt‐de Vries,Nadia Harbeck,Thomas Koenig,Oliver Hartmann,(unknown),Dimo Dietrich,Viktor Magdolen,Henk Portengen,Maxime P. Look,Jan G.M. Klijn,Ralf Lesche,Manfred Schmitt,Sabine Maier,John A. Foekens,John W.M. Martens	85
8	Association of DNA Methylation of Phosphoserine Aminotransferase with Response to Endocrine Therapy in Patients with Recurrent Breast Cancer 2005 ·Cancer Research ·John W.M. Martens,Inko Nimmrich,Thomas Koenig,Maxime P. Look,Nadia Harbeck,Fabian Model,(unknown),Joan Bolt‐de Vries,Anieta M. Sieuwerts,Henk Portengen,Marion E. Meijer‐van Gelder,Christian Piepenbrock,Alexander Olek,Heinz Höfler,Marion Kiechle,Jan G.M. Klijn,Manfred Schmitt,Sabine Maier,John A. Foekens	102
9	Clinical relevance of biologic factors in male breast cancer 2001 ·Breast Cancer Research and Treatment ·Marion E. Meijer‐van Gelder,Maxime P. Look,Joan Bolt‐de Vries,Harry A. Peters,Jan G.M. Klijn,John A. Foekens	43
10	Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer 1999 ·British Journal of Cancer ·J Witte,Fred C.G.J. Sweep,J.G.M. Klijn,(unknown),Harry A. Peters,Maxime P. Look,(unknown),J.J.T.M. Heuvel,Joan Bolt‐de Vries,T J Benraad,John A. Foekens	37
11	Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients 1998 ·British Journal of Cancer ·John A. Foekens,Maxime P. Look,Joan Bolt‐de Vries,Marion E. Meijer‐van Gelder,Wim L.J. van Putten,J.G.M. Klijn	153
12	Effect of testosterone deprivation on expression of the androgen receptor in rat prostate, epididymis and testis 1992 ·International Journal of Andrology ·Leen J. Blok,John M.S. Bartlett,Joan Bolt‐de Vries,(unknown),Albert O. Brinkmann,Gerhard F. Weinbauer,Eberhard Nieschlag,J. Anton Grootegoed	48
13	Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: Effects of cyproterone acetate 1992 ·The Journal of Steroid Biochemistry and Molecular Biology ·Frank H. de Jong,(unknown),Joan Bolt‐de Vries,E. Mulder,J. Blom,Fritz H. Schroeder	5
14	Androgen receptor heterogeneity and phosphorylation in human LNCaP cells 1990 ·Biochemical and Biophysical Research Communications ·J.H. van Laar,Joan Bolt‐de Vries,Netty D. Zegers,Jan Trapman,Albert O. Brinkmann	40
15	Circulating testosterone, prostatic nuclear androgen receptor and time to progression in patients with metastatic disease of the prostate treated by orchiectomy 1989 ·Urological Research ·(unknown),Joan Bolt‐de Vries,Marinus A. Blankenstein,Frank H. de Jong,Fritz H. Schröder	4
16	The human androgen receptor is a 110 kDa protein 1989 ·Molecular and Cellular Endocrinology ·J.H. van Laar,Joan Bolt‐de Vries,Marleen M. Voorhorst‐Ogink,Albert O. Brinkmann	27
17	Prediction of time to progression after orchiectomy by the nuclear androgen receptor content from multiple biopsy specimens in patients with advanced prostate cancer 1988 ·The Prostate ·(unknown),Joan Bolt‐de Vries,Marinus A. Blankenstein,Fritz H. Schröder	14
18	In situ photolabelling of the human androgen receptor 1988 ·Journal of Steroid Biochemistry ·A.O. Brinkmann,George G. J. M. Kuiper,Joan Bolt‐de Vries,E. Mulder	11
19	Transplantable human prostatic carcinoma (PC‐82) in athymic nude mice. II. Tumor growth and androgen receptors 1988 ·The Prostate ·G.J. van Steenbrugge,Joan Bolt‐de Vries,Marinus A. Blankenstein,Albert O. Brinkmann,Fritz H. Schröder	5
20	Effect of Hormone Treatment on Prostatic Acid Phosphatase in a Serially Transplantable Human Prostatic Adenocarcinoma (PC-82) 1983 ·The Journal of Urology ·G.J. van Steenbrugge,Marinus A. Blankenstein,Joan Bolt‐de Vries,Johannes C. Romijn,Fritz H. Schröder,Pirkko Vihko	33

About Joan Bolt‐de Vries

Joan Bolt‐de Vries is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Immunology and Allergy, having authored 34 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hormonal and reproductive studies (15 papers), Prostate Cancer Treatment and Research (10 papers) and Cancer Cells and Metastasis (9 papers). The work is most often cited by research in Cancer Research (598 citations), Oncology (591 citations) and Endocrinology, Diabetes and Metabolism (231 citations). Joan Bolt‐de Vries has collaborated with scholars based in Netherlands, Germany and Spain. Frequent co-authors include John A. Foekens, Maxime P. Look, John W.M. Martens, Anieta M. Sieuwerts, Marion E. Meijer‐van Gelder, Jaco Kraan, Bianca Mostert, Stefan Sleijfer, Petra van der Spoel and Jan‐Willem Gratama. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact